Huron Consulting Group Boosts Market Access in APAC through Windrose's Acquisition of Zenith

Strategic Acquisition Enhances Market Access Consultancy in Asia-Pacific

Windrose Consulting Group recently announces its acquisition of Zenith Access Network, a consultancy renowned for its expertise in market access within Greater China and emerging Asia-Pacific markets. Founded in 2016, Zenith has established a strong track record, engaging with over 180 life science companies and providing services that include market and stakeholder landscaping, pricing research, reimbursement assessments, and payer engagement. This acquisition represents a significant strategic move for Windrose, which seeks to enhance its capabilities in a region characterized by complex market access challenges.

Shuang Wen, the Founding Director of Zenith, steps into the role of Head of APAC at Windrose following the acquisition, bringing extensive industry knowledge and a robust network among public and private payers, health technology assessment (HTA) reviewers, and patient advocacy groups across key markets such as Greater China, Indonesia, Thailand, and Singapore. Both Wen and Windrose’s Managing Partner, Matthew Storer, express enthusiasm for the partnership, emphasizing its potential to deliver tailored client services. By combining Zenith's regional insights with Windrose’s global expertise, the two firms aim to create comprehensive access solutions that will help clients navigate the intricate life sciences landscape in Asia-Pacific.

The acquisition aligns with Windrose's mission to support clients in optimizing patient access to healthcare innovations. By integrating Zenith's specialized knowledge into its existing framework, Windrose enhances its value proposition in a market that continues to evolve rapidly due to regulatory changes and varied payer landscapes. This collaboration is expected to yield significant benefits for clients seeking efficient strategies to overcome barriers to market entry and improve patient access to essential therapies.

In related industry news, Denison Consulting and Newmeasures have merged to form Denison Consulting, Inc., a move aimed at enhancing employee listening and organizational performance. The merger combines Denison’s Organizational Health Model, supported by vast data from over five million employees, with Newmeasures' expertise in employee feedback programs. This partnership is designed to transform how organizations can leverage employee insights to drive meaningful business outcomes.

Additionally, a study released by 121G Consulting, in collaboration with Windham Brannon Tax Advisory, emphasizes the financial advantages of conducting research and development (R&D) domestically. The study highlights significant tax benefits and strategic advantages for companies that partner with U.S.-based R&D providers, reinforcing the notion that location plays a critical role in maximizing innovation and financial returns.